The Interference between SARS-CoV-2 and Tyrosine Kinase Receptor Signaling in Cancer
암에서 SARS-CoV-2와 티로신 키나제 수용체 신호 전달 간의 간섭
Review
Published on
Journal: International Journal of Molecular Sciences [Category] SARS, 신약개발, 유전자 메커니즘, 치료제,
Journal: International Journal of Molecular Sciences [Category] SARS, 신약개발, 유전자 메커니즘, 치료제,
[키워드] accelerate
activated
addition
approach
Cancer
cancer cell
Cancer cells
cell proliferation
Characteristics
clinically
coronavirus
correlation
COVID-19
Critical
diagnosed
division
downstream
downstream signaling pathways
drug
Drug repurposing
dysregulation
dysregulations
EGFR
help
identify
infection rate
information
interact
interfere
Interference
Invasion
kinase
management
mechanism
MERS
metabolism
pandemic
pathogen
Pathways
Patient
phenotypic
produced
receptor
repurposing
required
Research
research and development
resource
SARS-CoV-1
SARS-CoV-1 and -2
SARS-CoV-2
Scientific community
signaling pathway
signaling pathways
strongly related
Structure
therapeutic agent
therapeutic agents
Therapeutic compounds
treat
Treatment
tyrosine
tyrosine kinase
tyrosine kinase receptor
Viral
viral infection
Viral vector
virus
viruses
[DOI] 10.3390/ijms22094830 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/ijms22094830 PMC 바로가기 [Article Type] Review